Facebook
Twitter
LinkedIn
ForwardDuke Lung Transplant Symposium 2017
Overview
For 25 years, Duke’s lung transplant program
has been one of the largest and most
successful in the world. With over 1700 lung
transplants performed, our team understands
all aspects of lung transplant, from
process to planning, organization and the
incorporation of the multidisciplinary components
that are key to good outcomes. Our
team is experienced in lung transplant across
the age and disease spectrum, as well as
multiorgan transplant. We are also leaders
in transplant research, having contributed to
much of the pivotal knowledge that guides
current practices and as the recipients of the
first lung-focused $13 million NIH Clinical
Trials in Organ Transplantation (CTOT) grant
which lead to advances in future care.
This symposium is designed to help you
understand how to optimize lung transplant
candidate selection as well as perioperative
and long-term management of lung transplant
recipients. This is a unique opportunity
to broaden your transplant expertise and
learn the pearls and pitfalls of lung transplant
from our established team of experts.
Target Audience
This activity is designated for transplant coordinators, nurses, pharmacists, and physicians that care for or are interested in the care of the pre and post lung transplant patient.
Learning Objectives
At the conclusion of this activity, all participants should be able to:
1. Identify current practice guidelines in order to provide optimal care to patients undergoing lung transplant.
2. Identify current initiatives at Duke and internationally, surrounding the care of the lung transplant patient.
3. Identify and discuss risks associated with lung transplant allograft rejection and dysfunction as well as current identification and treatment practices in the lung transplant patient.
4. Identify and discuss potential complications associated with immunosuppression, infection, rejection, and effective management in the lung transplant patient.
5. Identify current practices in organ allocation and management in the United States as well as abroad.
6. Identify and discuss potential complications associated with psychological concerns in the pre and post lung transplant patient
Faculty
Activity Director
Omar H. Mohamedaly, MD
Medical Instructor
Lung Transplant Program
Associate Medical Director
Adult Cystic Fibrosis Program
Duke University Medical Center
Mitchell E. Horwitz, MD
Professor of Medicine
Director, Adult Blood and Marrow Transplant Program
Duke University Medical Center
Matthew G. Hartwig, MD
Associate Professor of Surgery
Program Director Minimally Invasive Thoracic Surgery Fellowship
Division of Thoracic Surgery
Duke University Medical Center
Krista K. Ingle, PhD,
Assistant Professor of Medical Psychology
Department of Psychiatry and Behavioral Sciences
Duke University Medical Center
Joy Kerner, MA CCC-SLP
Clinical Speech-Language Pathologist, Senior Clinician
Division of Speech Pathology & Audiology
Duke University Medical Center
John M. Reynolds, MD
Associate Professor of Medicine
Medical Director
Lung Transplant Program
Division of Pulmonary, Allergy, and Critical Care Medicine
Duke University Medical Center
Jacob A. Klapper, MD
Assistant Professor of Surgery
Division of Cardiothoracic Surgery
Duke University Medical Center
Dirk Van Raemdonck, MD, PhD
Department of Thoracic Surgery
University Hospital Gasthuisberg
Leuven, Belgium
Danielle Niedfeldt, RN, JD
President/CEO
Carolina Donor Services
Cindy M. Lawrence, RN, BSN, MSN
Lung Transplant Coordinator
Duke Transplant Center
Duke University Medical Center
Amanda Hulbert, PharmD, BCPS
Lung Transplant Clinical Pharmacist
Duke University Medical Center
Cameron R. Wolfe, MD, MPH
Assistant Professor of Medicine
Division of Infectious Diseases
Duke University Medical Center
Accreditation
Available Credit
- 13.00 ACPE - Pharmacist
- 13.00 Attendance
- 13.00 JA Credit - AH